Clinical Trials List
Protocol Number
2008-12-01 - 2010-11-30
Phase II
Study ended1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- Woei-Cheang Shyu Division of Neurology
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
0 participants
